Arbutus Biopharma (ABUS) Net Margin Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
33,908.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
33,908.00 |
| Dec 31, 2025 |
-7,041.00 |
| Sep 30, 2025 |
-116,610.00 |
| Jun 30, 2025 |
12,295.00 |
| Mar 31, 2025 |
-126,528.00 |
| Dec 31, 2024 |
-11,115.00 |
| Sep 30, 2024 |
-74,699.00 |
| Jun 30, 2024 |
-17,382.00 |
| Mar 31, 2024 |
-23,867.00 |
| Dec 31, 2023 |
-5,519.00 |
| Sep 30, 2023 |
99,860.00 |
| Jun 30, 2023 |
76,074.00 |
| Mar 31, 2023 |
88,504.00 |
| Dec 31, 2022 |
135,054.00 |
| Sep 30, 2022 |
249,136.00 |
| Jun 30, 2022 |
389,376.00 |
| Mar 31, 2022 |
369,885.00 |
| Dec 31, 2021 |
56,235.00 |
| Sep 30, 2021 |
97,795.00 |
| Jun 30, 2021 |
-101,686.00 |
